Welcome to our dedicated page for Faraday Future Intelligent Electric SEC filings (Ticker: FFAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Faraday Future Intelligent Electric Inc. (FFAI) SEC filings page on Stock Titan provides access to the company’s official regulatory documents, along with AI-powered tools to help interpret them. Faraday Future is a Delaware-incorporated, California-based global shared intelligent electric mobility ecosystem company whose Class A common stock and public warrants trade on The Nasdaq Stock Market under the symbols FFAI and FFAIW, as disclosed in its current reports.
Through this page, readers can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss Faraday Future’s intelligent electric vehicle programs, FX brand strategy, Global Embodied AI (EAI) Industry Bridge Strategy, risk factors, and going-concern considerations. Current reports on Form 8-K capture material events such as changes in auditors, production and launch updates for the FX Super One, adoption of charging standards, capital structure changes, and investments or agreements with partners.
Faraday Future’s registration statements, including Form S-1 filings, describe offerings of its Class A common stock, financing arrangements involving convertible notes and settlement shares, and the company’s status as an emerging growth company. Proxy statements on Schedule 14A outline proposals such as increases in authorized share capital and a potential corporate name change to Faraday Future AI Electric Vehicle Inc., as well as details about special meetings of stockholders.
Stock Titan enhances these filings with AI-powered summaries that explain key sections in plain language, highlight important risks, and point out items relevant to shareholders, such as capital authorizations and governance changes. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K, S-1, and proxy filings appear quickly, while structured views make it easier to follow Faraday Future’s regulatory history and understand how its intelligent electric vehicle and EAI strategies are reflected in formal disclosures.
Faraday Future Intelligent Electric Inc. furnished an 8-K announcing it issued a press release with certain third quarter 2025 financial results and its 2025 outlook. The company also referenced an investor presentation used during a conference call discussing the quarter and outlook.
The materials are provided as Exhibits 99.1 (press release) and 99.2 (investor presentation) and are furnished under Items 2.02 and 8.01, rather than filed. No specific financial figures are included in this excerpt.
Faraday Future Intelligent Electric Inc. announced it is adopting the North American Charging Standard (NACS), which will provide future Faraday Future and Faraday X drivers access to Tesla’s Supercharger network. The company disclosed this in a Form 8-K.
The announcement was communicated via a press release dated November 12, 2025, which was furnished as Exhibit 99.1. The press release was furnished and not deemed “filed” under the Exchange Act.
Faraday Future Intelligent Electric Inc. filed an 8-K under Item 8.01 to furnish a press release about the final launch event for its FX Super One. The event is scheduled to take place in Dubai, UAE on October 28, 2025.
The company stated the information is being furnished and not deemed filed under the Exchange Act. The filing includes Exhibit 99.1 (Press Release dated October 15, 2025) and the cover page interactive data file.
Faraday Future Intelligent Electric Inc. filed a current report to note that it has closed an investment in Qualigen Therapeutics, Inc., a company listed on Nasdaq under the symbol QLGN. The closing occurred on September 30, 2025, and was announced the same day in a press release.
The report classifies this as an "Other Events" disclosure and includes the press release as an exhibit. No financial terms or strategic details of the investment are described in the excerpt, but the filing confirms that the transaction has been completed rather than merely planned.
Faraday Future Intelligent Electric Inc. reported a planned strategic investment in Qualigen Therapeutics. On September 19, 2025, the company agreed to invest approximately $40.7 million, payable in cash, USDC stablecoin or other cryptocurrencies, to purchase Qualigen common stock at $2.246 per share and/or Series B preferred stock at $1,000 per share. At closing, Faraday Future will gain the right to designate multiple Qualigen directors, including the board chair, and have its designees appointed as Co‑CEO and CFO of Qualigen.
Qualigen must file a resale registration statement for the purchased securities within 45 days and seek stockholder approval by late October 2025 or November 2025, with repeated meetings required until approval is obtained. Separately, Faraday Future shareholders approved amendments increasing authorized common stock from 167,245,313 to 232,470,985 shares and authorized preferred stock from 12,900,000 to 17,931,000 shares, and added 9,500,000 shares to the 2021 stock incentive plan, while rejecting a proposed name change.